BRAF (V600E) mutation in isthmic malignant thyroid nodules
暂无分享,去创建一个
[1] A. Alibrandi,et al. Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? , 2014, Thyroid : official journal of the American Thyroid Association.
[2] T. Pellegrino,et al. Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation? , 2013, Endocrine.
[3] F. Trimarchi,et al. Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes. , 2013, Thyroid : official journal of the American Thyroid Association.
[4] J. Shah,et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. , 2010, Thyroid : official journal of the American Thyroid Association.
[5] D. Pager,et al. Estimating Risk , 2010, Social psychology quarterly.